Loading…
Vapor Cigs LLC was warned about manufacturing and selling e-liquid tobacco products without obtaining required premarket authorization under the Family Smoking Prevention and Tobacco Control Act. The FDA determined that the company's e-liquid products, which are derived from tobacco and intended for human consumption, constituted "new tobacco products" subject to FDA jurisdiction but lacked the necessary marketing authorization orders required since the deeming rule effective August 8, 2016. The company was found to be in violation of sections 201(rr), 901(b), and 910 of the Federal Food, Drug, and Cosmetic Act by offering these products for sale and distribution without compliance with premarket review requirements.